Jagsonpal Pharmaceuticals acquires Aequitas Healthcare

M&A / JV 29 Jun 2026 · Announced· ✓ Verified

Jagsonpal Pharmaceuticals, a publicly listed pharmaceutical company, has acquired Aequitas Healthcare Private Limited through a transaction disclosed to the National Stock Exchange (NSE). The acquisition was communicated to the exchange via a Regulation 30 general update filing on 29 June 2026. The consideration amount, payment structure, and strategic rationale were not disclosed in the headline announcement; full details are expected in the formal exchange filing and company press release.

Why it mattersMaterial acquisition by a listed pharma entity triggers mandatory continuous disclosure under SEBI Regulation 30; consider implications for consolidated financials, integration roadmap, and potential earn-out/deferred consideration structures in the stock exchange announcement.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals